Scarica l'app Stockscreener
20.88
0.85%
-0.18
Dopo l'orario di chiusura:
20.90
0.02
+0.10%
Precedente Chiudi:
$21.06
Aprire:
$21.04
Volume 24 ore:
84,016
Relative Volume:
0.47
Capitalizzazione di mercato:
$863.51M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.14%
1M Prestazione:
+10.42%
6M Prestazione:
+0.14%
1 anno Prestazione:
+11.48%
Intervallo 1D:
$20.81
$21.10
Intervallo di 1 settimana:
$20.53
$21.38
Portata 52W:
$18.42
$22.60
Abrdn Healthcare Opportunities Fund Stock (THQ) Company Profile
Nome
Abrdn Healthcare Opportunities Fund
Settore
Industria
Telefono
-
Indirizzo
-
Confronta THQ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
THQ
Abrdn Healthcare Opportunities Fund
|
20.88 | 863.51M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
9.43 | 3.49B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
33.46 | 2.94B | 0 | 0 | 0 | 0.00 |
|
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
|
15.48 | 2.44B | 0 | 0 | 0 | 0.00 |
|
UTF
Cohen Steers Infrastructure Fund Inc
|
24.39 | 2.35B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
20.65 | 2.31B | 0 | 0 | 0 | 0.00 |
Abrdn Healthcare Opportunities Fund Borsa (THQ) Ultime notizie
THQ: Improved Performance But Trades At Fair Value - Seeking Alpha
Abrdn U.S. Closed-End Funds Announce Distribution Payment Details - WICZ
Infrastructure & Healthcare Fund Alert: Two Top CEFs Announce Generous Yields Over 10% - StockTitan
Two Areas of Opportunity for 2025 - Stock Investor
Fierce Biotech Fundraising Tracker '25: Atalanta snares $97M series B; Helicore raises $65M - Fierce Biotech
abrdn U.S. Closed-End Funds Announce Distribution Payment Details - ACCESS Newswire
2 Big Dividends To Buy And Hold Forever - Seeking Alpha
A Gift Of Yields Up To 11% - Seeking Alpha
French PE fund Jeito Capital invests in global biopharma growth with Aviceda and XyloCor Therapeutics - EU-Startups
Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials - BioSpace
Jeito Capital announces significant participation in upsized $207.5 million Series C financing in Aviceda Therapeutics to advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials - The Manila Times
THQ: Healthcare Weakness Presents Opportunity, But Potentially Better Alternatives Exist - Seeking Alpha
My #1 Income Strategy For 2025 (Safety, 14% Dividends On The Table) - Contrarian Outlook
abrdn Private Equity Opportunities (LON:APEO) Trading Down 1% – Here’s What Happened - Defense World
THQ: Tempest On The Horizon (NYSE:THQ) - Seeking Alpha
ACPabrdn Income Credit Strategies Fund Latest Stock News & Market Updates - StockTitan
THW: Revisiting The 11.8% Healthcare Yielder As Thesis Plays Out (NYSE:THW) - Seeking Alpha
Health and Safety - University of Aberdeen
The Wellcome Trust Institutional Strategic Support Fund (ISSF @ Aberdeen) - University of Aberdeen
THQ (Tekla Healthcare Opportunities Fund) Change In Prepaid Assets : $-0.1 Mil (TTM As of Mar. 2024) - GuruFocus.com
Nuvig Therapeutics Announces $161 Million Series B Financing and Progression to Phase 2 Development with Novel, Second-Generation Immunomodulator - Business Wire
THQ (Tekla Healthcare Opportunities Fund) Enterprise Value : $1,081.0 Mil (As of Dec. 05, 2024) - GuruFocus.com
THQ (Tekla Healthcare Opportunities Fund) Earnings Power Va - GuruFocus.com
THQ (Tekla Healthcare Opportunities Fund) Cash Flow from Fi - GuruFocus.com
THQ (Tekla Healthcare Opportunities Fund) Purchase Of Busin - GuruFocus.com
THQ (Tekla Healthcare Opportunities Fund) Purchase Of Inves - GuruFocus.com
THQ (Tekla Healthcare Opportunities Fund) Sale Of Business : $0.0 Mil (TTM As of Mar. 2024) - GuruFocus.com
Nature and health — a perfect partnership - Scottish Natural Heritage
abrdn Funds ASGI, THQ Declare Distributions; ASGI Yields 8.46% 5-Year Return - StockTitan
THW: Valuation Is Attractive Once More (Rating Upgrade) - Seeking Alpha
THQ (Tekla Healthcare Opportunities Fund) Growth Rank : 0 (As of Nov. 26, 2024) - GuruFocus.com
HQH: Declines Bring Potential Opportunity (NYSE:HQH) - Seeking Alpha
Polar Capital operating profits climb 21% despite lack of performance fees - Investment Week
abrdn Healthcare Opportunities Fund declares $0.18 dividend - MSN
Brazil’s Patria could exceed target on first post-Abrdn secondaries fund - Secondaries Investor
Saba indicates UK buying opportunity with renewed Abrdn stake - Citywire Investment Trust Insider
Need $450 a Month in Passive Income? Invest $5K Each in These 9 Funds - 24/7 Wall St.
Asia ex Japan equities: abrdn versus Schroder - Fund Selector Asia
QuotedData’s Investment Companies Quarterly Review – Third quarter of 2024 - QuotedData
abrdn Total Dynamic Dividend Fund (AOD) Announces Update on Proposed A... - Moscow-Pullman Daily News
I Am Banking On The Silver Tsunami With Big Dividends - Seeking Alpha
THQ: Discount Narrows Further, But Healthcare Remains Attractive (NYSE:THQ) - Seeking Alpha
PortfolioPlus S&P Small Cap ETF (NYSEARCA:PPSC) Trading Up 1.3% – Time to Buy? - Defense World
Abrdn Healthcare Opportunities Fund Azioni (THQ) Dati Finanziari
Non sono disponibili dati finanziari per Abrdn Healthcare Opportunities Fund (THQ). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.86%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):